IntelGenX
Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and.
Launch date
Employees
Market cap
AUD45.1m
Enterprise valuation
AUD69m (Public information from Sep 2024)
Share price
$0.17 IGXT
Montreal Quebec (HQ)
Authorizing premium user...